$58.98 3.9%
BRKR Stock Price vs. AI Score
Data gathered: November 6

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally.


Bruker
Price $58.98
Target Price Sign up
Volume 2,010,000
Market Cap $8.99B
Year Range $56.61 - $94.13
Dividend Yield 0.34%
PE Ratio 24.83
Analyst Rating 78% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24801M416M385M7.6M65M0.520
Q1 '24722M369M353M51M92M0.530
Q4 '23855M424M430M206M265M0.800
Q3 '23743M360M383M88M134M0.740
Q2 '23682M341M341M57M84M0.500

Insider Transactions View All

ROSENTHAL BOB filed to sell 30,963 shares at $63.1.
August 16 '24
Requardt Hermann Fritz filed to sell 23,147 shares at $89.6.
March 6 '24
Requardt Hermann Fritz filed to sell 24,375 shares at $90.1.
March 6 '24
Busse Falko filed to sell 32,859 shares at $84.5.
March 1 '24
Busse Falko filed to sell 34,359 shares at $85.
March 1 '24

What is the Market Cap of Bruker?

The Market Cap of Bruker is $8.99B.

What is Bruker's PE Ratio?

As of today, Bruker's PE (Price to Earnings) ratio is 24.83.

What is the current stock price of Bruker?

Currently, the price of one share of Bruker stock is $58.98.

How can I analyze the BRKR stock price chart for investment decisions?

The BRKR stock price chart above provides a comprehensive visual representation of Bruker's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bruker shares. Our platform offers an up-to-date BRKR stock price chart, along with technical data analysis and alternative data insights.

Does BRKR offer dividends to its shareholders?

Yes, Bruker (BRKR) offers dividends to its shareholders, with a dividend yield of 0.34%. This dividend yield represents Bruker's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bruker in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Bruker?

Some of the similar stocks of Bruker are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.